Shengshan Group

Shengshan Group

Shengshan Group was founded in 1997 by Xu Erming and remains a privately held corporate investor anchored in Hangzhou. The firm's operating core spans three dyeing-and-finishing divisions and a technical-fiber unit, making it one of China's concentrated textile-plate conglomerates. Its wealth originates in industrial processing — not technology or finance — distinguishing it from the post-exit venture offices that dominate private-market headlines. The group deploys retained earnings directly into venture-stage healthcare and biotechnology alongside established GPs. Its deal flow leans heavily on a partnership with Qiming Venture Partners, a Shanghai-based venture firm managing over $9 billion in assets. Co-investment relationships extend to Tencent Holdings on specific biotech bets, including MedSci Healthcare. Geographically, Shengshan's footprint is dual-track: industrial production facilities sit in Hangzhou and Jiaxing, while portfolio exposure reaches mainland China's coastal innovation clusters. The firm does not publicly disclose an AUM figure, but its balance sheet is backed by physical plant assets — dyeing lines, cold-chain logistics parks — that generate the surplus capital deployed into venture. President Xu Erming leads the operating company and its investment activity without a separate institutional investment committee. In August 2025, Shengshan launched an internal AI-and-digital-transformation training program for its dyeing division, signaling broader modernization intent. The group maintains a philanthropic lane through the Shengshan Scholarship at Zhejiang Sci-Tech University and direct support for village elders near its facilities. A distinct asset-management vehicle, Shengshan Asset Management (Shanghai) Co., Ltd., is majority-owned by Gan Shixiong, who is identified as a 51% shareholder and investment liaison. The structural differentiator is the operating-company dividend model. Instead of recycling management fees or carried interest, Shengshan funds venture commitments from textile-margin surplus. That architecture imposes a different risk posture than pooled-fund vehicles: long-duration capital that doesn't face redemption pressure, deployed episodically when industrial cash flows permit. The result is a corporate investor that looks like a single-family office in practice, but reports as a diversified industrial group.